Xilio Therapeutics, Inc. (XLO)
7.60
-0.10
(-1.30%)
USD |
NASDAQ |
Jun 08, 16:00
7.60
0.00 (0.00%)
After-Hours: 20:00
Xilio Therapeutics Total Liabilities (Quarterly) : 90.94M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Verastem, Inc. | 146.03M |
| KalVista Pharmaceuticals, Inc. | 348.57M |
| Opus Genetics, Inc. | 112.62M |
| Sensei Biotherapeutics, Inc. | 4.582M |
| ACADIA Pharmaceuticals, Inc. | 357.16M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 163.49M |
| Shareholders Equity (Quarterly) | 72.54M |
| Debt to Equity Ratio | 0.0915 |
| Current Ratio | 3.590 |
| Net Debt Paydown Yield | 0.62% |